Form 8-K INTEGRA LIFESCIENCES For: Feb 18

Go back to Form 8-K INTEGRA LIFESCIENCES For: Feb 18

Integra LifeSciences (IART) PT Raised to $75 at Truist Securities

February 18, 2021 4:21 PM EST

Truist Securities analyst Kaila Krum raised the price target on Integra LifeSciences (NASDAQ: IART) to $75.00 (from $70.00) while maintaining a Buy rating.

The analyst comments "Integra announced Q4 2020 results, with revenue of $389 million coming in at the high end of its preliminary range that... More